+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "FDA Warning Letter"

FDA Inspection Essentials (Recorded) - Product Thumbnail Image

FDA Inspection Essentials (Recorded)

  • Training
  • June 2021
  • 2 Days
  • Global
From
From
Establishing a Robust Data Integrity Program - Webinar (Recorded) - Product Thumbnail Image

Establishing a Robust Data Integrity Program - Webinar (Recorded)

  • Webinar
  • February 2019
  • 90 Minutes
  • Global
Data Integrity - FDA's Latest Thinking - Webinar (Recorded) - Product Thumbnail Image

Data Integrity - FDA's Latest Thinking - Webinar (Recorded)

  • Webinar
  • November 2018
  • 180 Minutes
  • Global
From
GMP Laboratory Training - Pack of 7 Courses - Product Thumbnail Image

GMP Laboratory Training - Pack of 7 Courses

  • Training
  • 12 Hours
  • Global
From
From
6-Hour Virtual Seminar on Audit like the FDA - Webinar (Recorded) - Product Thumbnail Image

6-Hour Virtual Seminar on Audit like the FDA - Webinar (Recorded)

  • Webinar
  • August 2022
  • 360 Minutes
  • Global
From
Writing Excellent SOPs - Webinar (Recorded) - Product Thumbnail Image

Writing Excellent SOPs - Webinar (Recorded)

  • Webinar
  • May 2023
  • 90 Minutes
  • Global
From
From
Loading Indicator

The FDA Warning Letter market within the context of Pharmaceutical Manufacturing is a market that focuses on the enforcement of regulations and standards set by the U.S. Food and Drug Administration (FDA). Companies in this market are responsible for ensuring that their products meet the FDA's requirements for safety, efficacy, and quality. Companies must also comply with the FDA's Good Manufacturing Practices (GMPs) and other regulations. Companies that fail to meet these standards may receive a warning letter from the FDA, which can result in fines, product recalls, or other penalties. Companies in this market must also be aware of the latest developments in the industry, such as new regulations or changes to existing regulations. Some companies in the FDA Warning Letter market include Pfizer, Merck, Johnson & Johnson, Novartis, and GlaxoSmithKline. Show Less Read more